MSF Field Research > 1 Published Research and Commentary > Other Diseases > Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/204590
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
Ritmeijer Limited Eff Amph B Leish Ethiopia CID.pdf256KbAdobe PDF

Title: Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
Authors: Ritmeijer, Koert
ter Horst, Rachel
Chane, Solomon
Aderie, Endashaw Mengistu
Piening, Turid
Collin, Simon M
Davidson, Robert N
Affiliation: Public Health Department, Médecins Sans Frontières, Amsterdam, the Netherlands. koert.ritmeijer@amsterdam.msf.org
Citation: Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. 2011, 53 (12):e152-8 Clin. Infect. Dis.
Journal: Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America
Issue Date: Dec-2011
URI: http://hdl.handle.net/10144/204590
DOI: 10.1093/cid/cir674
PubMed ID: 22016502
Abstract: Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human immunodeficiency virus (HIV).
Language: en
ISSN: 1537-6591
Rights: Published by: Infectious Diseases Society of America and University of Chicago Press Archived on this site with permission and copyright 2011 by the Infectious Diseases Society of America
Appears in topics: Other Diseases

Related articles on PubMed
bullet
bullet
bullet
Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.
Mueller M, Ritmeijer K, Balasegaram M, Koummuki Y, Santana MR, Davidson R
2007 Jan
bullet
Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
Salih NA, van Griensven J, Chappuis F, Antierens A, Mumina A, Hammam O, Boulle P, Alirol E, Alnour M, Elhag MS, Manzi M, Kizito W, Zachariah R
2014 Feb
bullet
See all 187 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Sep 21, 2014